Incidence of Cardiac Complications of Covid-19: A Retrospective Study from a Tertiary Care Center
Main Article Content
Abstract
Introduction: COVID-19 has been linked to a variety of cardiac conditions, including myocarditis, acute coronary syndrome, and heart failure. On the other hand, neither the prevalence nor the clinical characteristics of COVID-19 patients' cardiac problems are known. The purpose of this research was to investigate the frequency of COVID-19 cardiac issues among patients who were admitted to tertiary care centres for medical treatment.
Methods: A retrospective study was conducted on a group of 500 patients who were diagnosed with COVID-19 and admitted to a tertiary care facility between January 2021 and June 2022. After analysing the patients' medical records, data was collected on the patients' demographics, comorbidities, laboratory results, electrocardiograms (ECG), echocardiograms, and cardiac biomarkers. An examination of the frequency of cardiac issues and a determination of the nature of the connection between cardiac complications and death rates are both included.
Results: The findings showed that out of a total of 500 patients, 75 (15%) had heart problems. Myocarditis, acute coronary syndrome, and heart failure were the most common cardiac complications. The percentage of patients who passed away due to cardiac difficulties was three times higher (35%) than the percentage of patients who did not have cardiac complications (10%). Patients who had cardiac issues, on average, were older (65.2± 8.7) than patients who did not have cardiac complications, who were 54.6±10.4 years old. According to a multivariate study, factors such as an individual's age, being male, having hypertension or diabetes, and having elevated cardiac biomarkers were all independent predictors of cardiac issues in COVID-19 individuals.
Conclusion: In conclusion, cardiac issues are associated with a greater mortality rate, and they are rather common among COVID-19 patients who are admitted to tertiary care centres. Early diagnosis and treatment of heart conditions may be beneficial. Patients diagnosed with COVID-19 have a more favourable prognosis.
Article Details
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;: PMID: 31986264; PMCID: PMC7159299.
World Health Organization. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. Accessed March 20, 2021. https://www.who.int/emergencies/disease/novel-coronavirus-2019/situation-reports/
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950. PMID: 32211816; PMCID: PMC7097841.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017. Erratum in: JAMA Cardiol. 2020 Jul 1;5(7):848. PMID: 32219356; PMCID: PMC7101506..
Zheng Y, Ma Y, Zhang J, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260.
Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Mount Sinai COVID Informatics Center. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8. PMID: 32517963; PMCID: PMC7279721.
Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388. Erratum in: Eur Heart J. 2020 Dec 21;41(48):4591. PMID: 32383763; PMCID: PMC7239204.
Basu-Ray I, Almaddah Nk, Adeboye A. Cardiac Manifestations Of Coronavirus (COVID-19) [Updated 2023 Jan 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556152/
Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, De Cobelli F, Tresoldi M, Cappelletti AM, Basso C, Godino C, Esposito A. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020 May 14;41(19):1861-1862. doi: 10.1093/eurheartj/ehaa286. PMID: 32267502; PMCID: PMC7184339.
Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11. PMID: 32275347; PMCID: PMC7262276.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031.
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. 2020 Jul 7;142(1):68-78. doi: 10.1161/CIRCULATIONAHA.120.047549. Epub 2020 Apr 15. PMID: 32293910.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262-265.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21. PMID: 32200663.